NeoPharm, Inc. - SWOT Analysis
| Product Code | DAT06584 |
| Publication Date | October 2008 |
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 22 |
| ISBN Number | not applicable |
NeoPharm, Inc. - SWOT Analysis
Datamonitor's NeoPharm - SWOT Analysis company profile is the essential source for top-level company data and information. NeoPharm - SWOT Analysis examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
NeoPharm is a biopharmaceutical company engaged in the research, development, and commercialization of drugs for the treatment of cancer. The company has built its drug development program around its two technology platforms: a tumor-targeting toxin platform and NeoLipid liposomal drug delivery system. NeoPharm primarily operates in the US. NeoPharm is headquartered in Waikegan, Illinois and employs about 17 people. The company did not record any revenues during the financial year (FY) ended December 2007, as there was no product revenue from sales of NeoPhectin and NeoPhectin-AT during the year. The operating loss of the company was $14.4 million during FY2007, as compared to an operating loss of $35.7 million over 2006. The net loss was $11 million in FY2007, as compared to a net loss of $33.2 million over 2006.
Scope of the Report
- Provides all the crucial information on NeoPharm required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting NeoPharm in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of NeoPharm
- Data is supplemented with details on NeoPharm history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from NeoPharm
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available
This report covers the following industry codes:
SIC Code: 2836
NAICS Code: 325414
Contents
- This product typically includes the following sections:
- SWOT COMPANY PROFILE: NEOPHARM
- Key Facts: NeoPharm
- Company Overview: NeoPharm
- Business Description: NeoPharm
- Company History: NeoPharm
- Key Employees: NeoPharm
- Key Employee Biographies: NeoPharm
- Products & Services Listing: NeoPharm
- Products & Services Analysis: NeoPharm
- SWOT analysis: NeoPharm
- Strengths: NeoPharm
- Weaknesses: NeoPharm
- Opportunities: NeoPharm
- Threats: NeoPharm
- Company View: NeoPharm
- Top Competitors: NeoPharm
- Location and Subsidiary: NeoPharm
- Head Office: NeoPharm
- Other Locations and Subsidiaries: NeoPharm